What does Apotheek Xavier Ameloot do?

Apotheek Xavier Ameloot is a pharmacy in Poperinge. Private Limited, started on 22 March 2005, 1 establishment.

What is the address of Apotheek Xavier Ameloot?

The registered office of Apotheek Xavier Ameloot is located at Grote Markt 23, 8970 Poperinge.

Is Apotheek Xavier Ameloot still active?

Yes. According to the CBE (30 October 2026) Apotheek Xavier Ameloot is active, legal situation “Normale toestand”, started on 22 March 2005.

Is Apotheek Xavier Ameloot registered on Peppol?

Yes, Apotheek Xavier Ameloot is registered on the Peppol network with ID 0208:0872659609.

What is the enterprise number of Apotheek Xavier Ameloot?

The enterprise number of Apotheek Xavier Ameloot is BE0872659609.

When was Apotheek Xavier Ameloot founded?

Apotheek Xavier Ameloot was founded on 22 March 2005.

Who are the directors of Apotheek Xavier Ameloot?

According to the 2025 annual accounts, the directors of Apotheek Xavier Ameloot are: Top B.V..

Is Apotheek Xavier Ameloot a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 March 2005; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Apotheek Xavier Ameloot make in 2025?

Apotheek Xavier Ameloot posted a profit after taxes of € 99,125 in financial year 2025.

What is the revenue of Apotheek Xavier Ameloot?

As a small company, Apotheek Xavier Ameloot is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 419,421.

How much does an employee at Apotheek Xavier Ameloot earn?

The average wage cost per full-time employee at Apotheek Xavier Ameloot was € 45,100 in 2024: staff costs of € 175,878 for 3.9 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

Apotheek Xavier Ameloot (Private Limited) - Poperinge

Dossier Apotheek Xavier Ameloot, printed on 30 October 2026 from databakkes.be/en/0872659609/apotheek-xavier-ameloot. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Apotheek Xavier Ameloot from Poperinge, company number BE0872659609, closed financial year 2025 with a result of € 99,125 after tax. For that financial year Apotheek Xavier Ameloot recorded a gross margin of € 419,421 and equity of € 726,691. Compared with financial year 2024, the result moved from € 87,583 to € 99,125. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 30, 2026.

What it is worth Growing

€ 726,691

▲ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 99,125

▲ 13% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 5,281

▼ 75% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 701,691.

People and assets in 2025

Wage cost

€ 182,138

▲ 4% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 151,086

▲ 21% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 10 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 760,114

▲ 69% vs 2024

€ 55,090 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.

Owed to suppliers

€ 190,163

▼ 46% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 34,792

▲ 6% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 299,128 Gross margin 2022: € 299,128 First fiscal year in the series	€ 438,687 Gross margin 2023: € 438,687 ▲ 47% vs 2022 (€ 299,128) Favourable step	€ 340,448 Gross margin 2024: € 340,448 ▼ 22% vs 2023 (€ 438,687) Unfavourable step	€ 419,421 Gross margin 2025: € 419,421 ▲ 23% vs 2024 (€ 340,448) Favourable step	▲ 23%
Profit after taxes	€ 104,819 Profit after taxes 2022: € 104,819 First fiscal year in the series	€ 240,425 Profit after taxes 2023: € 240,425 ▲ 129% vs 2022 (€ 104,819) Favourable step	€ 87,583 Profit after taxes 2024: € 87,583 ▼ 64% vs 2023 (€ 240,425) Unfavourable step	€ 99,125 Profit after taxes 2025: € 99,125 ▲ 13% vs 2024 (€ 87,583) Favourable step	▲ 13%
Equity	€ 449,559 Equity 2022: € 449,559 First fiscal year in the series	€ 539,984 Equity 2023: € 539,984 ▲ 20% vs 2022 (€ 449,559) Favourable step	€ 627,567 Equity 2024: € 627,567 ▲ 16% vs 2023 (€ 539,984) Favourable step	€ 726,691 Equity 2025: € 726,691 ▲ 16% vs 2024 (€ 627,567) Favourable step	▲ 16%
Total debts	€ 541,014 Total debts 2022: € 541,014 First fiscal year in the series	€ 887,507 Total debts 2023: € 887,507 ▲ 64% vs 2022 (€ 541,014) Unfavourable step	€ 1,079,154 Total debts 2024: € 1,079,154 ▲ 22% vs 2023 (€ 887,507) Unfavourable step	€ 1,185,050 Total debts 2025: € 1,185,050 ▲ 10% vs 2024 (€ 1,079,154) Unfavourable step	▲ 10%
Cash	€ 32,120 Cash 2022: € 32,120 First fiscal year in the series	€ 42,718 Cash 2023: € 42,718 ▲ 33% vs 2022 (€ 32,120) Favourable step	€ 21,158 Cash 2024: € 21,158 ▼ 50% vs 2023 (€ 42,718) Unfavourable step	€ 5,281 Cash 2025: € 5,281 ▼ 75% vs 2024 (€ 21,158) Unfavourable step	▼ 75%
Land & buildings	-	-	-	€ 147,307 Land & buildings 2025: € 147,307 First fiscal year in the series
Retained profit	€ 424,559 Retained profit 2022: € 424,559 First fiscal year in the series	€ 514,984 Retained profit 2023: € 514,984 ▲ 21% vs 2022 (€ 424,559) Favourable step	€ 602,567 Retained profit 2024: € 602,567 ▲ 17% vs 2023 (€ 514,984) Favourable step	€ 701,691 Retained profit 2025: € 701,691 ▲ 16% vs 2024 (€ 602,567) Favourable step	▲ 16%
Dividend	€ 50,000 Dividend 2022: € 50,000 First fiscal year in the series	€ 150,000 Dividend 2023: € 150,000 ▲ 200% vs 2022 (€ 50,000) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 150,000) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 201,922 Bank debt 2022: € 201,922 First fiscal year in the series	€ 187,902 Bank debt 2023: € 187,902 ▼ 7% vs 2022 (€ 201,922) Favourable step	€ 450,513 Bank debt 2024: € 450,513 ▲ 140% vs 2023 (€ 187,902) Unfavourable step	€ 760,114 Bank debt 2025: € 760,114 ▲ 69% vs 2024 (€ 450,513) Unfavourable step	▲ 69%
Balance sheet total	€ 990,573 Balance sheet total 2022: € 990,573 First fiscal year in the series	€ 1,427,491 Balance sheet total 2023: € 1,427,491 ▲ 44% vs 2022 (€ 990,573) Unchanged	€ 1,706,721 Balance sheet total 2024: € 1,706,721 ▲ 20% vs 2023 (€ 1,427,491) Unchanged	€ 1,911,741 Balance sheet total 2025: € 1,911,741 ▲ 12% vs 2024 (€ 1,706,721) Unchanged	▲ 12%
Employees (FTE)	3.5 Employees (FTE) 2022: 3.5 First fiscal year in the series	3.7 Employees (FTE) 2023: 3.7 ▲ 0.2 vs 2022 (3.5) Unchanged	3.9 Employees (FTE) 2024: 3.9 ▲ 0.2 vs 2023 (3.7) Unchanged	-

Key figures of Apotheek Xavier Ameloot, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to Apotheek Xavier Ameloot?

What happened at Apotheek Xavier Ameloot in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 30, 2026 New annual accounts for financial year 2025: profit of € 99,125 (▲ 13% vs 2024). Source: NBB ↗
Apr 1, 2005 New establishment in Poperinge. KBO
Mar 22, 2005 Start of the company according to the CBE. KBO

In short

From € 104,819 profit in 2022 to € 99,125 profit in 2025.

Paid € 105,889 in corporate taxes since 2022.

Best year ever: 2023, with € 240,425 profit.

On average € 87,300 of value added per employee in 2024.

Original PDFs at the National Bank ↗

Management

TOP 100%

The stake of TOP comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek Xavier Ameloot

Behind Apotheek Xavier Ameloot is Top B.V.. The shares are held by TOP (100%).

Directors

According to the 2025 annual accounts

Top B.V.

Director · represented by Eveliene Top

Shareholders

TOP

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Grote Markt 23

8970 Poperinge

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0872.659.609

VAT number

BE 0872.659.609

Registered office

Grote Markt 23, 8970 Poperinge

Names & denominations

Apotheek Xavier Ameloot

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

22 March 2005

Peppol

Active · Active since 31 Aug 2023

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek Xavier Ameloot

Financials

What happened to Apotheek Xavier Ameloot?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions